We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SYRS market cap is 5.67M. The company's latest EPS is USD -6.1334 and P/E is -0.03.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.76M | 386k | 0 | 0 | 0 |
| Operating Income | -34.26M | -27.51M | -30.92M | -27.42M | -26.18M |
| Net Income | -40.14M | -64.38M | -3.71M | -23.33M | -6.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.98M | 15.09M | 23.49M | 14.88M | 9.94M |
| Operating Income | -77.74M | -82.3M | -99.42M | -135.87M | -128.99M |
| Net Income | -75.44M | -84.04M | -86.56M | -94.65M | -164.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 147.8M | 168.17M | 134.73M | 106.72M | 85M |
| Total Liabilities | 111.49M | 151.51M | 119.67M | 113.07M | 96.12M |
| Total Equity | 36.3M | 16.66M | 15.06M | -6.35M | -11.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 149.98M | 213.25M | 182.94M | 244.49M | 168.17M |
| Total Liabilities | 70.79M | 122.7M | 97.72M | 116.75M | 151.51M |
| Total Equity | 79.18M | 90.55M | 85.22M | 127.74M | 16.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -91.15M | -109.71M | -31.1M | -60.77M | -81.45M |
| Investing | 35.82M | 37.34M | -24.64M | 427k | 427k |
| Financing | 82k | 43.46M | -265k | -224k | -224k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -60.25M | -57.36M | -99.54M | -123.07M | -109.71M |
| Investing | -11.73M | 46.66M | -52.65M | 67.19M | 37.34M |
| Financing | 65.99M | 142.95M | 70.51M | 131.05M | 43.46M |
| Market Cap | 5.67M |
| Price to Earnings Ratio | -0.03 |
| Price to Sales Ratio | 0.57 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.34 |
| Dividend Yield | - |
| Shares Outstanding | 26.83M |
| Average Volume (1 week) | 1M |
| Average Volume (1 Month) | 3.55M |
| 52 Week Change | -96.77% |
| 52 Week High | 7.96 |
| 52 Week Low | 0.183 |
| Spread (Intraday) | 0.01 (5.92%) |
| Company Name | Syros Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.syros.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
